← Evidence map

ArticleHemaSphere2022

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia.

Olav Versloot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35356797